| Cold but not sympathomimetics activates human brown adipose tissue in vivo AM Cypess, YC Chen, C Sze, K Wang, J English, O Chan, AR Holman, ... Proceedings of the National Academy of Sciences 109 (25), 10001-10005, 2012 | 349 | 2012 |
| A review of autologous stem cell transplantation in lymphoma U Zahid, F Akbar, A Amaraneni, M Husnain, O Chan, IB Riaz, A McBride, ... Current hematologic malignancy reports 12, 217-226, 2017 | 116 | 2017 |
| Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia O Chan, C Talati, L Isenalumhe, S Shams, L Nodzon, M Fradley, K Sweet, ... Blood advances 4 (3), 530-538, 2020 | 77 | 2020 |
| Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes AM Hunter, RS Komrokji, S Yun, N Al Ali, O Chan, J Song, M Hussaini, ... Blood advances 5 (4), 1017-1028, 2021 | 48 | 2021 |
| Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant S Yun, O Chan, D Kerr, ND Vincelette, A Idrees, Q Mo, K Sweet, JE Lancet, ... Blood advances 4 (14), 3435-3442, 2020 | 37 | 2020 |
| Chronic myelomonocytic leukemia diagnosis and management O Chan, A Renneville, E Padron Leukemia 35 (6), 1552-1562, 2021 | 31 | 2021 |
| Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia C Pavlovsky, O Chan, C Talati, J Pinilla-Ibarz Future Oncology 15 (3), 257-269, 2019 | 31 | 2019 |
| Acute lymphocytic leukemia Y Puckett, O Chan | 29 | 2017 |
| Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC) S Yun, R Sharma, O Chan, ND Vincelette, DA Sallman, K Sweet, ... Leukemia research 84, 106194, 2019 | 26 | 2019 |
| Genomic characteristics and prognostic significance of co‐mutated ASXL1/SRSF2 acute myeloid leukemia DR Richardson, DM Swoboda, DT Moore, SM Johnson, O Chan, ... American journal of hematology 96 (4), 462-470, 2021 | 21 | 2021 |
| Burkitt lymphoma presenting as an intracardiac mass: case report and review of literature O Chan, M Igwe, CS Breburda, S Amar The American Journal of Case Reports 17, 553, 2016 | 19 | 2016 |
| Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy C Talati, AD Goldberg, A Przespolewski, O Chan, N Al Ali, J Kim, ... Leukemia research 93, 106367, 2020 | 18 | 2020 |
| Integrated human and murine clinical study establishes clinical efficacy of ruxolitinib in chronic myelomonocytic leukemia AM Hunter, H Newman, AE Dezern, DP Steensma, S Niyongere, ... Clinical Cancer Research 27 (22), 6095-6105, 2021 | 16 | 2021 |
| Cancer, Acute Lymphocytic Leukemia (ALL) Y Puckett, O Chan Treasure Island; StatPearls: Tampa, FL, USA, 2017 | 16 | 2017 |
| Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes LE Aguirre, N Al Ali, DA Sallman, S Ball, AG Jain, O Chan, ... Leukemia 37 (7), 1530-1539, 2023 | 14 | 2023 |
| Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia A Renneville, MM Patnaik, O Chan, E Padron, E Solary Leukemia 35 (10), 2739-2751, 2021 | 14 | 2021 |
| StatPearls Y Puckett, O Chan StatPearls Publishing, 2018 | 12 | 2018 |
| Phase 1/1b safety study of prgn-3006 ultracar-T in patients with relapsed or refractory CD33-positive acute myeloid leukemia and higher risk myelodysplastic syndromes DA Sallman, H Elmariah, K Sweet, A Mishra, CA Cox, M Chakaith, ... Blood 140 (Supplement 1), 10313-10315, 2022 | 11 | 2022 |
| Impact of TP53 gene mutation clearance and conditioning intensity on outcome in MDS or AML patients prior to allogeneic stem cell transplantation O Chan, A Hunter, C Talati, DA Sallman, H Asghari, J Song, M Hussaini, ... Blood 134, 149, 2019 | 11 | 2019 |
| Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations S Ball, TC Knepper, YE Deutsch, W Samra, JM Watts, TJ Bradley, O Chan, ... Cancer 128 (21), 3880-3887, 2022 | 10 | 2022 |
